-
Jan 30, 2025 | 
advanced.onlinelibrary.wiley.com | Yu Tang |Rui Liu |Jing Zhu |Qian He
1 Introduction Breast cancer (BC) is the most prevalent malignant tumor in women globally and one of the major causes of cancer-related death in women.[1] Breast cancer is divided into four subtypes based on IHC results for estrogen receptor (ERα), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), and the tumor cell proliferation index (Ki-67):[2] Luminal A, Luminal B, HER2 positive and basal-like breast cancer (BLBC).
-
Nov 10, 2024 | 
nature.com | Jing Zhu
AbstractEndoscopic bariatric surgery (EBS) is a new treatment for obesity. We compared the efficacy, safety, and probability of metabolic complications of different EBSs with laparoscopic sleeve gastrectomy (LSG). This systematic review and network meta-analysis (NMA) included searches of PubMed, Web of Science, and the Cochrane Library from January 1, 2017, to December 27, 2022, to find comparative trials of EBS procedures and EBS with LSG.
-
Aug 20, 2024 | 
onlinelibrary.wiley.com | Chenyang Li |Lili Sun |Jing Zhu |Xin Wang
DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.
-
May 12, 2024 | 
onlinelibrary.wiley.com | Jing Zhu |Chongyi Wei |Yuan Zhang |Ji Yang
Conflict of Interest The authors declare no conflict of interest. References 1 , , , Progr. Mater. Sci. 2009, 54, 137. 2 , , , , , , , ACS Appl. Mater. Interfaces 2016, 8, 14966. 3 , , , , , , , , Int. J. Extreme Manuf. 2020, 2, 032002. 4 , , , , , Chem. Soc. Rev. 2017, 46, 4168. 5 , , , , , RSC Adv. 2019, 9, 12470. 6 , , , , Nat. Rev. Microbiol. 2022, 20, 671. 7 , , , , , Environ. Microbiol. 2013, 15, 2879. 8 , , , , , Progr. Org. Coat. 2020, 142, 105557.
-
Apr 12, 2024 | 
dx.doi.org | Jing Zhu |Qing Zhang |Wen Wang
-
Apr 1, 2024 | 
mdpi.com | Zhihui Li |Ziwei Wang |Wenyang Zhang |Jing Zhu
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Jan 5, 2024 | 
mdpi.com | Vincent Ho |Jing Zhu |Stephanie Lim |Liping Chung
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Oct 25, 2023 | 
onlinelibrary.wiley.com | Jing Zhu |Qi Lu |Li-Hua Pan |Bo-Yu Yan
1 INTRODUCTION Acute ST-segment elevation myocardial infarction (STEMI) is a critical disease in cardiovascular medicine that affects human health.1 An acute myocardial infarction (AMI) can damage the sinus and atrioventricular nodes resulting in atrial fibrillation (AF), which can arise as a result of problems with electrical conductivity.2 New-onset AF during hospitalization is an independent risk factor for in-hospital mortality in AMI,3 and it is also correlated with an increase in...
-
Sep 8, 2023 | 
pharmafocusamerica.com | Jing Zhu
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers. Ensuring these life-changing therapies successfully pass critical regulatory milestones on the journey to market requires gene therapy producers and their partners to demonstrate both flexibility and agility.
-
Jul 18, 2023 | 
mdpi.com | Rongzhi Chen |Jing Zhu |Lan Jiang |Lan LIU
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
